Trial Profile
A PROOF-OF-CONCEPT CLINICAL STUDY, TO ASSESS THE EFFECT OF GED-0507-34-Levo 80 mg Tablets IN INDUCTION OF REMISSION OF ACTIVE ULCERATIVE COLITIS [STUDIO CLINICO PER LA VERIFICA DELL`EFFETTO DI GED-0507-34-Levo COMPRESSE 80 MG NELL`INDUZIONE ALLA REMISSIONE DI COLITE ULCEROSA IN FASE ATTIVA]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Mar 2014
Price :
$35
*
At a glance
- Drugs GED 0507 34 Levo (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Giuliani
- 03 Feb 2014 Status changed from recruiting to completed according to European Clinical Trials Database record.
- 15 Mar 2012 New trial record